Digital Biomarkers

Multiple Sclerosis

The New McDonald Criteria: Is Your MS Study Ready?

Discover how the new McDonald criteria use imaging biomarkers such as the Central Vein Sign (CVS) to make earlier, more accurate MS diagnosis

Research use

Five Strategic Reasons to Include MRI Biomarkers in Your Next Parkinson’s Study

Parkinson’s Disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Over 750 industry clinical trials have been initiated for...

Multiple Sclerosis

Improving Multiple Sclerosis Diagnosis: Automating Central Vein Sign (CVS) Detection with QMENTA’s Imaging Hub

Learn how QMENTA simplifies central vein detection in Multiple Sclerosis. Our solution automates protocol adherence, sequence recognition, and white...

Parkinson's Disease

Unraveling Parkinson's: The Power of Neuroimaging Biomarkers

Advance Parkinson’s research with QMENTA's Imaging Hub: cutting-edge imaging, biomarker insights, and cloud-based tools for early detection and...

Multiple Sclerosis

Central Vein Sign: A Breakthrough in Multiple Sclerosis Diagnosis, Redefining McDonald Criteria

Discover how the Central Vein Sign (CVS) may enhance diagnostic accuracy, advance research outcomes, and influence the McDonald criteria.

Research use

The top 4 open-source software tools to measure cortical brain thickness, volumetry and brain morphometry.

Companies and technicians that are developing new algorithms to help researches and professionals to diagnose and measure diseases progression...